(Q30933471)

English

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

0 references

chronic obstructive pulmonary disease

0 references

object named as

Ian D Pavord

5

0 references

author name string

Steven Pascoe

1

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Nicholas Locantore

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Mark T Dransfield

3

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Neil C Barnes

4

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

publication date

12 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

The Lancet. Respiratory medicine

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

435-442

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled corticosteroids vs placebo for preventing COPD exacerbations: a systematic review and metaregression of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Number needed to treat in COPD: exacerbations versus pneumonias

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Spirometric reference values from a sample of the general U.S. population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary arterial enlargement and acute exacerbations of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Computed tomography assessment of pharmacological lung volume reduction induced by bronchodilators in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-2600(15)00106-X

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30933471&oldid=1546520564"